Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00564551|
Recruitment Status : Completed
First Posted : November 28, 2007
Last Update Posted : January 21, 2010
|Condition or disease||Intervention/treatment||Phase|
|Impaired Glucose Tolerance Type 2 Diabetes Metabolic Syndrome||Behavioral: High dairy and calcium intake Behavioral: Usual intake||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||49 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Impact of High Milk Product and Calcium Intake During Weight Loss on Markers of Insulin Resistance|
|Study Start Date :||October 2007|
|Actual Primary Completion Date :||April 2009|
|Actual Study Completion Date :||October 2009|
Active Comparator: 2
High dairy intake and calcium supplement. High intake of low-fat milk product intake (3-4 servings per day) plus one 350 mg calcium supplement per day during 500 kcal/day deficit diet.
Behavioral: High dairy and calcium intake
High intake of low-fat milk product intake (3-4 servings per day) plus one 350 mg calcium supplement per day during 500 kcal/day deficit diet.
Other Name: Jamieson Mega Cal™ Chewable Calcium (350 mg) tablet
Placebo Comparator: 1
Usual diet of low dairy and calcium intake. Usual intake of low milk product intake (1 serving/day) and low calcium intake with a placebo during a 500 kcal/day deficit diet.
Behavioral: Usual intake
Usual intake of low milk product intake (1 serving/day) and low calcium intake with a placebo during a 500 kcal/day deficit diet
- Weight loss [ Time Frame: 12 weeks ]
- Insulin and glucose response [ Time Frame: 12 weeks ]
- Inflammatory Markers [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564551
|Faculty of Kinesiology, Roger Jackson Centre for Health and Wellness Research|
|Calgary, Alberta, Canada, T2N 1N4|
|Principal Investigator:||Raylene A. Reimer, PhD, RD||University of Calgary|